Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Third-party claim

Rules 1.1.0 · as of 14 Sep 2026

Quote

Third-party claim

“Compass anticipates the launch of COMP360 in the first half of 2027 subject to FDA approval and following Drug Enforcement Administration (DEA) rescheduling.”
· Lil John and Owen Muir Respond to Compass Pathways Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile for Comp360 · substack post

Body of the Compass Pathways press release. Launch of COMP360 for TRD anticipated in H1 2027, conditional on FDA approval of the rolling NDA (final submission Q4 2026) and DEA rescheduling of psilocybin.

A quoted or paraphrased claim by someone else that the author does not adopt as their own.